<DOC>
	<DOC>NCT01744366</DOC>
	<brief_summary>One month degarelix/comparator treatment for prostate cancer in Chinese population</brief_summary>
	<brief_title>One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<criteria>Chinese male over 18 years Adenocarcinoma of the prostate Relevant disease status based on lab values and as judged by the physician Life expectancy of at least a year Previous hormonal treatment for prostate cancer Considered to be candidate for curative therapy Risk or history of any serious or significant health condition Has received an investigational drug within the last 28 days and no previous treatment with degarelix</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>